CIK 0001474167 · Non-accelerated filer<br>Smaller reporting company
Cosmos Health Inc.
Sign in to watch- Ticker
- COSM
- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 270611758
- Phone
- 312-536-3102
- Business address
- 5 AGIOU GEORGIOU, PILEA, THESSALONIKI, Greece, 55438
- Former names
- Cosmos Holdings Inc., PRIME ESTATES & DEVELOPMENTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-30 | Siokas Grigorios Chief Executive Officer | Purchase | +349,825 | $0.20 | $70K | 14,597,917 |
| 2026-07-29 | Terzis Georgios Chief Financial Officer | Grant or award | +328,407 | $0.18 | $60K | 2,563,805 |
| 2026-07-29 | Siokas Grigorios Chief Executive Officer | Purchase | +766,284 | $0.18 | $140K | 14,248,092 |
| 2026-06-16 | Terzis Georgios Chief Financial Officer | Purchase | +168,135 | $0.25 | $42K | 2,235,398 |
| 2026-06-11 | Siokas Grigorios Chief Executive Officer | Purchase | +218,447 | $0.21 | $45K | 13,481,808 |
| 2026-06-10 | Siokas Grigorios Chief Executive Officer | Purchase | +701,447 | $0.23 | $160K | 13,263,361 |
| 2026-05-19 | Karkantzos Theodoros Christos Director | Grant or award | +20,000 | $0.28 | $6K | 35,000 |
| 2026-05-19 | Karkantzos Theodoros Christos Director | Conversion · Restricted Stock Unit | −35,000 | 0 | ||
| 2026-05-19 | Hoidas John James Director | Grant or award | +20,000 | $0.28 | $6K | 50,000 |
| 2026-05-19 | Hoidas John James Director | Conversion · Restricted Stock Unit | −20,000 | 0 | ||
| 2026-05-19 | Demetriades Demetrios G. Secretary | Grant or award | +20,000 | $0.28 | $6K | 55,000 |
| 2026-05-19 | Demetriades Demetrios G. Secretary | Conversion · Restricted Stock Unit | −20,000 | 0 | ||
| 2026-05-19 | Aslidis Anastasios Director | Grant or award | +40,000 | $0.28 | $11K | 100,000 |
| 2026-05-19 | Aslidis Anastasios Director | Conversion · Restricted Stock Unit | −40,000 | 0 | ||
| 2026-05-19 | Bhutawala Suhel Director | Grant or award | +20,000 | $0.28 | $6K | 65,000 |
| 2026-05-19 | Bhutawala Suhel Director | Conversion · Restricted Stock Unit | −20,000 | 0 | ||
| 2026-05-19 | Terzis Georgios Chief Financial Officer | Grant or award | +850,000 | $0.28 | $241K | 2,067,263 |
| 2026-05-19 | Terzis Georgios Chief Financial Officer | Conversion · Restricted Stock Unit | −850,000 | 0 | ||
| 2026-05-19 | Siokas Grigorios Chief Executive Officer | Grant or award | +2,350,000 | $0.28 | $665K | 12,561,914 |
| 2026-05-19 | Siokas Grigorios Chief Executive Officer | Conversion · Restricted Stock Unit | −2,350,000 | 0 |
Page 1 of 16 · 314 trades